ADAR1 Capital Management »

Spero Therapeutics shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Spero Therapeutics (SPRO) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Spero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Spero Therapeutics held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spero Therapeutics by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $996k 744k 1.34
2024-06-30 $1.2M 919k 1.30
2024-03-31 $1.6M 927k 1.72
2023-12-31 $1.6M 1.1M 1.47

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding Spero Therapeutics

Frigate Ventures
Vanguard Group
Renaissance Technologies
Acadian Asset Management
Alphabet
ADAR1 Capital Management
BlackRock
Geode Capital Management
Monimus Capital Management
Atlas Venture Life Science Advisors
Mackenzie Financial
Bridgeway Capital Management
Citadel Advisors
State Street Corporation
DAFNA Capital Management

View all funds holding Spero Therapeutics